236 related articles for article (PubMed ID: 26320381)
1. Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
Martin NE; Stowell C; Huland H
Eur Urol; 2015 Dec; 68(6):e125-6. PubMed ID: 26320381
[No Abstract] [Full Text] [Related]
2. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
MacLennan S; Williamson PR; Lam TB
Eur Urol; 2015 Dec; 68(6):e123-4. PubMed ID: 26323947
[No Abstract] [Full Text] [Related]
3. Reply to Daniela Wittmann, Ted A. Skolarus' Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460-7.
Martin NE; Stowell C
Eur Urol; 2016 Jun; 69(6):e127. PubMed ID: 26873843
[No Abstract] [Full Text] [Related]
4. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
Wittmann D; Skolarus TA
Eur Urol; 2016 Jun; 69(6):e125-6. PubMed ID: 26873838
[No Abstract] [Full Text] [Related]
5. Standardization of patient-centered outcomes: less is more.
Ehdaie B; Eastham JA
Eur Urol; 2015 Mar; 67(3):468-9. PubMed ID: 25449205
[No Abstract] [Full Text] [Related]
6. Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
Martin NE; Massey L; Stowell C; Bangma C; Briganti A; Bill-Axelson A; Blute M; Catto J; Chen RC; D'Amico AV; Feick G; Fitzpatrick JM; Frank SJ; Froehner M; Frydenberg M; Glaser A; Graefen M; Hamstra D; Kibel A; Mendenhall N; Moretti K; Ramon J; Roos I; Sandler H; Sullivan FJ; Swanson D; Tewari A; Vickers A; Wiegel T; Huland H
Eur Urol; 2015 Mar; 67(3):460-7. PubMed ID: 25234359
[TBL] [Abstract][Full Text] [Related]
7. Reply to Kwang Hyun Kim and Koon Ho Rha's letter to the editor Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
Tosco L; Van den Bergh L; Joniau S
Eur Urol; 2013 Sep; 64(3):e57-8. PubMed ID: 23769590
[No Abstract] [Full Text] [Related]
8. Medically underserved populations: disparities in quality and outcomes.
Wong SL
J Oncol Pract; 2015 May; 11(3):193-4. PubMed ID: 25901055
[No Abstract] [Full Text] [Related]
9. Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.
Nabid A; Souhami L
Eur Urol; 2019 Mar; 75(3):e63. PubMed ID: 30773206
[No Abstract] [Full Text] [Related]
10. Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.
Kishan AU; Steinberg ML; Kupelian PA; King CR
Eur Urol; 2017 Nov; 72(5):e123-e124. PubMed ID: 28111115
[No Abstract] [Full Text] [Related]
11. Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy Y.C. Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol 2019;76:260-1.
Bessa A; Maclennan S; Enting D; Bryan R; Häggström C; Van Hemelrijck M
Eur Urol; 2019 Aug; 76(2):e45-e46. PubMed ID: 31109813
[No Abstract] [Full Text] [Related]
12. Reply to Runqiang Yuan and Hongxing Huang's Letter to the Editor re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214-20.
Sivaraman A; Barret E
Eur Urol; 2017 May; 71(5):e148-e149. PubMed ID: 28161029
[No Abstract] [Full Text] [Related]
13. Building Data Infrastructure to Evaluate and Improve Quality: PCORnet.
Corley DA; Feigelson HS; Lieu TA; McGlynn EA
J Oncol Pract; 2015 May; 11(3):204-6. PubMed ID: 25980016
[TBL] [Abstract][Full Text] [Related]
14. Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' letter to the editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.
Joniau S; Van den Bergh L
Eur Urol; 2013 Feb; 63(2):e21-2. PubMed ID: 23149147
[No Abstract] [Full Text] [Related]
15. Extending the quality and safety agenda from parenteral to oral chemotherapy.
Krzyzanowska MK; Powis M
J Oncol Pract; 2015 May; 11(3):198-201. PubMed ID: 25829521
[No Abstract] [Full Text] [Related]
16. Building Data Infrastructure to Evaluate and Improve Quality: The National Cancer Data Base and the Commission on Cancer's Quality Improvement Programs.
Shulman LN; McCabe R; Gay G; Palis B; McKellar D
J Oncol Pract; 2015 May; 11(3):209-12. PubMed ID: 25901051
[No Abstract] [Full Text] [Related]
17. Quality of care indicators for prostate cancer: progress toward consensus.
Miller DC; Saigal CS
Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
[TBL] [Abstract][Full Text] [Related]
18. Reply to Lorenzo Marconi, Steven MacLennan, Thomas B.L. Lam, et al's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
Derweesh IH; Mir MC; Autorino R
Eur Urol; 2017 Sep; 72(3):e61-e62. PubMed ID: 28642021
[No Abstract] [Full Text] [Related]
19. Reply to Thomas Zilli, Gilles Créhange and Olivier Chapet's Letter to the Editor re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267-73.
Rischmann P
Eur Urol; 2017 Jul; 72(1):e15-e16. PubMed ID: 28089305
[No Abstract] [Full Text] [Related]
20. Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's letter to the editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
Abdollah F; Briganti A
Eur Urol; 2013 Nov; 64(5):e103-4. PubMed ID: 23915876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
